%0 Case Reports
%T Psoriasiform graft-versus-host disease responded to secukinumab: A case report.
%A Gu Y
%A Sun J
%A Zhang J
%J Australas J Dermatol
%V 64
%N 4
%D 2023 Nov 31
%M 37650524
%F 2.481
%R 10.1111/ajd.14144
%X We describe a 9-year-old boy who developed generalised erythematous lesions 12 months after haematopoietic stem cell transplant (HSCT). Histopathology showed both features of psoriasis and graft-versus-host disease (GVHD). The lesions responded well to secukinumab, suggesting that IL-17A monoclonal antibody might be a treatment option for GVHD.